Why the study?
Does nisoldipine have higher vascular selectivity than nifedipine in human isolated coronary arteries and cardiac tissue?
Does nisoldipine have higher vascular selectivity than nifedipine in human isolated coronary arteries and cardiac tissue?
Nisoldipine exhibits higher vascular selectivity than nifedipine in human isolated coronary and cardiac tissues.
Answers are grounded in this paper and cite their sources.
Nisoldipine may show greater vascular selectivity than nifedipine in isolated tissues; leaves open clinical translation and requires human trials.
We have studied the action of nifedipine and nisoldipine on the contractile activity of human isolated coronary arteries and human isolated auricular and ventricular muscles. Nisoldipine depressed dose dependently the spontaneous rhythmic contractions displayed by the coronary artery preparations and at 1 nM abolished these contractions. Nisoldipine was twenty times more potent than nifedipine as an inhibitor of increase in tone induced by depolarization (100 mM K+). The rhythmic activity induced by serotonin (10 microM) was about five times more sensitive to nisoldipine than to nifedipine. In both auricular and ventricular preparations, isoprenaline evoked an increase in the rate of force development and in the rate of relaxation. Nifedipine was five times (ventricular muscles) and ten times (auricular muscles) more potent than nisoldipine as a negative inotropic agent. The present observations in human isolated preparations indicate that nisoldipine shows a higher vascular selectivity than nifedipine.
No takes yet. Share an insight, caveat, or question.
Godfraind et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: